James S. Scibetta, SVP, Chief Financial Officer at Pacira Pharmaceuticals, Inc. (PCRX), sold 15,000 shares at $99.83 ($1.5M) on 2014-08-08, disclosed to the SEC on 2014-08-11.
Scheduled sale ($1.5M) by SVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $99.22 | 5,000 | $496K | 33.2% |
| 2 | $99.83 | 10,000 | $998K | 66.8% |
| Total | $99.63 avg | 15,000 | $1.5M | 100% |
| Filing → |
| PCRX | SELL | 2017-06-07 | $170K | — | Filing → |
| PCRX | SELL | 2017-05-17 | $1.0M | — | Filing → |
| PCRX | SELL | 2017-01-19 | $1.5M | — | Filing → |